Physician profile
Christopher Patronella
NPI 1023183712
$38,141.72
in general payments reported to CMS, 2019-2025
19 companies · $1,549 in 2025
The $1,549 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $437 · 2021: $1,371 · 2022: $1,592 · 2023: $1,034 · 2024: $2,276 · 2025: $1,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,648 · Long Term Medical Supply Or Device Loan: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,647.73 |
| Long Term Medical Supply Or Device Loan | $211.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $29,988.49 | 2019-2022 | |
| Revance Therapeutics, INC. | $1,705.85 | 2024-2025 | Daxxify |
| Abbvie INC. | $1,228.63 | 2023-2025 | |
| Mentor Worldwide LLC | $926.62 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Sientra, INC. | $923.27 | 2019-2022 | |
| Merz North America, INC. | $669.12 | 2019-2022 | |
| Motiva USA, LLC | $529.97 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $468.70 | 2021 | |
| Davol INC. | $453.60 | 2022 | |
| Galderma Laboratories, L.P. | $340.55 | 2019-2025 | |
| Tela Bio, INC. | $290.16 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $211.00 | 2023 | Durasorb Monofilament Mesh |
| Pacira Pharmaceuticals Incorporated | $141.50 | 2019-2025 | Exparel |
| Ethicon US, LLC | $123.89 | 2021-2025 | Ethicon, Dermabond Prineo, Monocryl |
| Acacia Pharma INC | $42.73 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32.72 | 2025 | V-Loc 180 |
| Medline Industries LP | $24.53 | 2020 | |
| Apyx Medical Corporation | $21.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $19.39 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Patronella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.